logo
Select company
Select metric
378.97Capital Expenditures Coverage
VS
Market
99
Sector
97
Industry
88
History
65
$ 5.45Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information

Ticker

PBYI

Company Name

PUMA BIOTECHNOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PUMA BIOTECHNOLOGY INC - Capital Expenditures Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PBYI - CapEx Coverage Historical data
DateCapital ExpenditureCapital Expenditures CoverageNet Cash Flow - Operations
6/30/2025$ 117K378.97$ 44.34M
3/31/2025$ 117K267.38$ 31.28M
12/31/2024$ 56K694.96$ 38.92M
9/30/2024$ 85K397.25$ 33.77M
6/30/2024$ 92K362.42$ 33.34M
3/31/2024$ 140K254.37$ 35.61M
12/31/2023$ 140K192.92$ 27.01M
9/30/2023$ 95K255.13$ 24.24M
6/30/2023$ 68K454.13$ 30.88M
3/31/2023$ 00$ 13.71M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) CapEx Coverage stands at 24.24.
  • Over the past 5 years, PUMA BIOTECHNOLOGY INC's average CapEx Coverage has been 367.08.
  • The median CapEx Coverage for PUMA BIOTECHNOLOGY INC during this period was 352.86
  • PUMA BIOTECHNOLOGY INC reached its highest CapEx Coverage over the past 5 years at 889.13.
  • The lowest CapEx Coverage recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 16.8

PUMA BIOTECHNOLOGY INC's CapEx Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Coverage Benchmarks
CompanyCapEx Coverage
HRTX : HERON THERAPEUTICS INC -VNDA : VANDA PHARMACEUTICALS INC -MGNX : MACROGENICS INC -ENTA : ENANTA PHARMACEUTICALS INC -AGEN : AGENUS INC -ALEC : ALECTOR INC -ATRA : ATARA BIOTHERAPEUTICS INC -SGMO : SANGAMO THERAPEUTICS INC -CHRS : COHERUS ONCOLOGY INC -GLUE : MONTE ROSA THERAPEUTICS INC 7.17

Definition of Capital Expenditures Coverage

[Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for PUMA BIOTECHNOLOGY INC is calculated as follows: CF - Operations [ $ 7.97M ] / CapEx [ $ 329K ]
(=) CapEx Coverage [ 24.24 ]

PBYI - Capital Expenditures Coverage, Last 5 years

16.8

Minimum

Dec 31, 2020

889.13

Maximum

Sep 30, 2021

367.08

Average

352.86

Median

CapEx Coverage Benchmark Analysis

The chart above depicts the distribution of CapEx Coverage for companies in the Total Stock Market. The average CapEx Coverage of the companies is 4.42 with a standard deviation of 4.02.
The following table provides additional summary stats:
CapEx Coverage in the Market:
filtered constituents2.21K
min0.01
max17.91
average4.42
median3.01
std4.02